TradingView
RocketTickers
Feb 25, 2022 7:52 PM

US FDA approves Jardiance® (empagliflozin) to treat adults with  Long

NYSE:LLY1D
Eli Lilly and CompanyNYSE

Description

⋅
LLY: Eli Lilly and Company
2022-02-24 16:00:00
US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction
Beyond Technical Analysis
More